Dr. Eduardo Sanchez serves as Chief Medical Officer (CMO) for Prevention for the American Heart Association (AHA). He is the AHA clinical lead on Target:BP (a joint blood pressure control initiative with the American Medical Association) and KnowDiabetesbyHeartTM (a joint cardiovascular risk factor control initiative with the American Diabetes Association).. He is the Principal Investigator (PI) of the National Hypertension Control Initiative (NHCI), a recently announced blood pressure control cooperative agreement with the federal Office of Minority Health (OMH) and the Health Resources and Services Administration (HRSA). Prior to joining AHA, he served as Vice President and CMO for Blue Cross and Blue Shield of Texas (BCBSTX) and before that, he served as director of the Institute for Health Policy at the University of Texas (UT) School of Public Health. Dr. Sanchez served as Commissioner of the Texas Department of State Health Services from 2004 to 2006 and Commissioner of the Texas Department of Health from 2001 to 2004. He has served on numerous health-related boards and advisory committees at the local, state and national levels. Dr. Sanchez obtained his M.D. from the University of Texas (UT) Southwestern Medical School in Dallas, an M.P.H. from the UT Health Science Center at Houston School of Public Health, and an M.S. in biomedical engineering from Duke University. He holds a B.S. in biomedical engineering and a B.A. in chemistry from Boston University. Dr. Sanchez is board certified in family medicine.
AcademyHealth Board of Nominations Committee Member 2017 - 2020